IVZ250117P13000
- 0.05
- 0.000.00%
Invesco Newsroom
Has the continuous pullback in the medical Sector over the past four years created an opportunity? Invesco's Qiao Haiying: 2015 is the year of confidence restoration.
① After over four years of continuous callbacks, will the Pharmaceutical Sector welcome opportunities? ② With the restoration of confidence, in the eyes of fund managers, the Pharmaceutical Sector will "initially boil like a spring surging"; ③ In the sub-sectors, Innovative Drugs and the overseas chain are worth paying attention to.
S&P 500 Now up in 2025 After Broadening Rally Ahead of Trump Inauguration
Invesco Mortgage Capital (IVR) Gains But Lags Market: What You Should Know
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Invesco Is Maintained at Equal-Weight by Barclays
Invesco Analyst Ratings
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
Barclays Maintains Invesco(IVZ.US) With Hold Rating, Cuts Target Price to $18
Barclays Sticks to Their Hold Rating for Invesco (IVZ)
BMO Capital Maintains Invesco(IVZ.US) With Hold Rating, Raises Target Price to $19
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
BMO Capital Adjusts Price Target on Invesco to $19 From $20, Maintains Market Perform Rating
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
Express News | Invesco Ltd : BMO Cuts Target Price to $19 From $20
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
Is Invesco S&P 500 Equal Weight Energy ETF (RSPG) a Strong ETF Right Now?
Wall Street Today: JPM and Banking Leads Market Higher
TD Cowen Maintains Invesco(IVZ.US) With Buy Rating